Provider

Chronic Kidney Disease Risk Stratification transforms kidney care by identifying genetic and biomarker-based risk before functional decline occurs, enabling proactive, precision prevention strategies.

Colon Cancer Risk Stratification challenges the assumption that colorectal cancer is unpredictable. Through hereditary panels, biomarker analysis, and molecular diagnostics, precision medicine identifies risk years before routine screening begins, shifting care from late detection to proactive prevention.

Preserving Function Through Precision Vision Care redefines AMD management through predictive diagnostics, genetic profiling, and longitudinal monitoring strategies that support independence and healthy aging.

Rare diseases reveal the system’s gaps by highlighting how delayed diagnosis, fragmented data, and inequitable access prolong suffering. Precision sequencing and translational research can shorten the diagnostic odyssey and restore trust in care.

Veterans face disproportionate risks for cardiometabolic disorders, autoimmune diseases, and certain cancers. Phronetik’s precision medicine approach uses genomics to identify predispositions early, enabling customized prevention strategies that can stop disease before it starts.

By demystifying the misconception that “a risk gene means I’m doomed,” Phronetik fosters a model of care where every patient and every provider can approach genomic information with confidence, clarity, and a clear path forward.

Hospital-scale genomic programs integrate advanced sequencing into major health systems, empowering precision care for marginalized populations and forging a new era of equitable medicine.

Precision medicine can close gaps and correct biases to deliver better health outcomes for every patient in every community.